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We read with a great interest the article written by 
Davoodbeglou and colleagues entitled “Evaluation of 
Hepatitis B Infection Prevalence in Institutionalized 
Intellectually Disabled Children” which is recently 
published in your prestigious journal
1
. The authors 
concluded that HBV infection is more prevalent 
among institutionalized disabled children and that we 
should change our health policies for HBV infection 
management in this population. They have conducted 
a valuable study with an important subject in a high 
risk population for hepatitis. Despite our interest to 
the findings of Davoodbeglou et al. study there are 
some challenging points about their work; so we 
think that some comments may be of benefit. The 
first, authors have claimed a higher prevalence of 
HBV infection among vaccinated children in 
comparison with those with no or undetermined 
vaccination history. While there are studies in which 
the efficacy of neonatal HBV immunization has been 
proven
2
. How the authors justify this finding?  
In addition the authors have not mentioned the 
sampling method of their study which is the crucial 
factor of prevalence studies. This may seriously affect 
the results of study. Also the time period in which the 
study was conducted has not been determined by the 
authors. Was it after or before distribution of national 
vaccination program for hepatitis B? In this regard we 
should be aware of the maximum age of disabled 
individuals included in the study.  
In conclusion we appreciate the valuable effort of the 
authors; however we were wondering if we could 
kindly ask them to interpret better our concerns. 
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